Rapamycin-insensitive mTORC1 activity controls eIF4E:4E-BP1 binding

Area of Science:

• Molecular Biology
• Cell Signaling
• Biochemistry

Background:

• Mammalian target of rapamycin (mTOR) signaling is crucial for cell growth and metabolism.
• mTOR exists in two complexes, mTORC1 and mTORC2, with distinct sensitivities to rapamycin.
• Phosphorylation of 4E-binding protein 1 (4E-BP1) by mTOR regulates protein synthesis initiation.

Purpose of the Study:

• To clarify the role of specific 4E-BP1 phosphorylation sites in regulating eIF4E binding.
• To differentiate the mechanisms of rapamycin and mTOR kinase domain inhibitors.

Main Methods:

• Utilized serine (Ser)-to-alanine (Ala) and threonine (Thr)-to-Ala phosphorylation site mutants of 4E-BP1.
• Assessed the impact of these mutations on the binding of 4E-BP1 to eukaryotic initiation factor 4E (eIF4E).

Main Results:

• Demonstrated that rapamycin-insensitive phosphorylation of 4E-BP1 at threonine 46 (Thr46) is sufficient to block eIF4E binding.
• Identified Thr46 phosphorylation as a key event in inhibiting cap-dependent translation initiation.

Conclusions:

• The initial, rapamycin-insensitive phosphorylation of 4E-BP1 at Thr46 is critical for preventing eIF4E:4E-BP1 complex formation.
• This finding distinguishes the action of second-generation mTOR kinase domain inhibitors from rapamycin analogues, impacting drug development.